Nicotinamide adenine dinucleotides (NAD+/NADH) play an essential role in cellular redox reactions and many biological processes. Altered NAD+/NADH levels and redox state may be associated with development of neurodegenerative diseases and psychotic disorders. 31P MRS is currently the only non-invasive technique to measure NAD+/NADH levels and redox state in human brain in vivo. However, the present technique suffers two major drawbacks: (1) the severe overlapping of the NAD+/NADH signals with the α-ATP resonance, and (2) the distorted baseline underneath these signals. Here we present a novel spectral editing method that allows resolution of NAD+/NADH from α-ATP at baseline.